Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL719 (Bactoderm, Bactroban, BRL 4910A, BRL-4910A, Centany, Mupirocin, NSC-759182, Pseudomonic acid, Trans-pseudomonic acid, Turixin) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Isoleucine--tRNA ligase in Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3879837] [UniProtKB: P56690] | ||||||||
ChEMBL | Inhibition of recombinant Thermus thermophilus HB8 IleRS H581S/L583I double mutant assessed as suppression of L-[14C]isoleucyl-tRNA(Ile) formation | B | 4.82 | pKi | 15000 | nM | Ki | Medchemcomm (2016) 7: 1535-1545 |
ChEMBL | Inhibition of recombinant Thermus thermophilus HB8 IleRS H581N/L583F double mutant assessed as suppression of L-[14C]isoleucyl-tRNA(Ile) formation | B | 5.56 | pKi | 2730 | nM | Ki | Medchemcomm (2016) 7: 1535-1545 |
ChEMBL | Inhibition of recombinant Thermus thermophilus HB8 IleRS H581L/L583H double mutant assessed as suppression of L-[14C]isoleucyl-tRNA(Ile) formation | B | 5.64 | pKi | 2310 | nM | Ki | Medchemcomm (2016) 7: 1535-1545 |
ChEMBL | Inhibition of recombinant Thermus thermophilus HB8 wild type IleRS assessed as suppression of L-[14C]isoleucyl-tRNA(Ile) formation | B | 6.6 | pKi | 250 | nM | Ki | Medchemcomm (2016) 7: 1535-1545 |
ChEMBL | Inhibition of recombinant Thermus thermophilus HB8 IleRS L583F mutant assessed as suppression of L-[14C]isoleucyl-tRNA(Ile) formation | B | 7.22 | pKi | 60 | nM | Ki | Medchemcomm (2016) 7: 1535-1545 |
Isoleucyl-tRNA synthetase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3235] [UniProtKB: P41252] | ||||||||
ChEMBL | Compound was evaluated for inhibitory activity against Isoleucyl-tRNA synthetase | B | 9.1 | pIC50 | 0.8 | nM | IC50 | Bioorg Med Chem Lett (1997) 7: 2805-2808 |
Isoleucyl-tRNA synthetase in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3657] [UniProtKB: P00956] | ||||||||
ChEMBL | Competitive inhibition of Escherichia coli Isoleucyl-tRNA synthetase | B | 8.6 | pKi | 2.5 | nM | Ki | Eur J Med Chem (2011) 46: 5227-5236 [PMID:21968372] |
Plasmodium falciparum isoleucyl-tRNA synthetase in Plasmodium falciparum 3D7 [GtoPdb: 3168] [UniProtKB: Q8I5G6] | ||||||||
GtoPdb | - | - | 7.24 | pIC50 | 57.4 | nM | IC50 | Proc Natl Acad Sci U S A (2011) 108: 1627-32 [PMID:21205898] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]